✦ LIBER ✦

198 Specific Adverse Events Predict Survival Benefit in Early Breast Cancer Patients Treated with Exemestane in the Dutch/Belgian TEAM Trial

✍ Scribed by D. Fontein; D. Houtsma; E.T.M. Hille; W.M. Meershoek-Klein Kranenbarg; H. Putter; C. Seynaeve; L.Y. Dirix; R. Paridaens; C.J.H. van de Velde; J.W.R. Nortier

Book ID: 117662108
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 58 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(12)70266-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

87. Specific adverse events predict surv

87. Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors – A TEAM trial analysis

✍ Fontein, D.; Hadji, P.; Seynaeve, C.; Hasenburg, A.; Paridaens, R.; Vannetzel, J 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Specific Adverse Events Predict Survival

Specific Adverse Events Predict Survival Benefit in Patients Treated With Tamoxifen or Aromatase Inhibitors: An International Tamoxifen Exemestane Adjuvant Multinational Trial Analysis

✍ Fontein, D. B. Y.; Seynaeve, C.; Hadji, P.; Hille, E. T. M.; van de Water, W.; P 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 290 KB